Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
ALPINE IMMUNE SCIENCES, INC. (NVLS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2022 |
SC 13D/A
| Alpine ImmunoSciences, L.P. reports a 8.6% stake in Alpine Immune Sciences, Inc. |
| 09/27/2022 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 9.3% stake in Alpine Immune Sciences, Inc. |
| 09/27/2022 |
SC 13D/A
| Decheng Capital China Life Sciences USD Fund III, L.P. reports a 17.6% stake in Alpine Immune Sciences, Inc. |
| 02/15/2022 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 10.8% stake in Alpine Immune Sciences, Inc. |
| 11/12/2021 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 14.4% stake in Alpine Immune Sciences, Inc. |
| 09/21/2021 |
SC 13D/A
| Decheng Capital China Life Sciences USD Fund III, L.P. reports a 19.6% stake in ALPINE IMMUNE SCIENCES, INC. |
| 09/21/2021 |
SC 13D/A
| Alpine ImmunoSciences, L.P. reports a 12.2% stake in Alpine Immune Sciences, Inc. |
| 09/21/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 10% stake in Alpine Immune Sciences, Inc. |
| 12/30/2020 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 13.4% stake in Alpine Immune Sciences, Inc. |
| 12/22/2020 |
SC 13D/A
| Alpine ImmunoSciences, L.P. reports a 17.1% stake in Alpine Immune Sciences, Inc. |
| 07/31/2020 |
SC 13D/A
| Decheng Capital China Life Sciences USD Fund III, L.P. reports a 17.7% stake in ALPINE IMMUNE SCIENCES, INC. |
| 07/31/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/30/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 11.5% stake in Alpine Immune Sciences, Inc. |
| 07/30/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/23/2019 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 20.4% stake in Alpine Immune Sciences, Inc. |
| 01/22/2019 |
SC 13D/A
| Alpine ImmunoSciences, L.P. reports a 23.7% stake in Alpine Immune Sciences, Inc. |
| 08/20/2018 |
SC 13D/A
| Flynn James E reports a 5% stake in Alpine Immune Sciences, Inc. |
| 01/26/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/25/2018 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 23.8% stake in Alpine Immune Sciences, Inc. |
| 08/22/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/28/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/24/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 09/20/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
|
|